BIOMAT Database Logo BIOMAT Database Logo

Cytochrome P450-3A phenotyping using midazolam is not altered by OATP1B1 polymorphisms. 2013

V C Ziesenitz, and J Weiss, and W E Haefeli, and G Mikus

UI MeSH Term Description Entries
D008297 Male Males
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D027361 Organic Anion Transporters Proteins involved in the transport of organic anions. They play an important role in the elimination of a variety of endogenous substances, xenobiotics and their metabolites from the body. Membrane Transport Proteins, Organic Anion,OAT Transport Protein,OATP Transporter,Organic Anion Transport Polypeptide,Organic Anion Transport Polypeptides,Organic Anion Transport Protein,Organic Anion Transporter,OAT Transport Proteins,OATP Proteins,OATP Transporters,Organic Anion Transport Proteins,Anion Transporter, Organic,Anion Transporters, Organic,Protein, OAT Transport,Transport Protein, OAT,Transport Proteins, OAT,Transporter, OATP,Transporter, Organic Anion,Transporters, OATP,Transporters, Organic Anion
D029362 Organic Anion Transporters, Sodium-Independent A subclass of ORGANIC ANION TRANSPORTERS that do not rely directly or indirectly upon sodium ion gradients for the transport of organic ions. Sodium-Independent Organic Anion Transporters,Organic Anion Transporters, Sodium Independent,Sodium Independent Organic Anion Transporters

Related Publications

V C Ziesenitz, and J Weiss, and W E Haefeli, and G Mikus
Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping.
June 2001, Pharmacogenetics,
V C Ziesenitz, and J Weiss, and W E Haefeli, and G Mikus
Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.
December 2002, Clinical pharmacology and therapeutics,
V C Ziesenitz, and J Weiss, and W E Haefeli, and G Mikus
Cytochrome P450 3A polymorphisms and immunosuppressive drugs.
January 2005, Pharmacogenomics,
V C Ziesenitz, and J Weiss, and W E Haefeli, and G Mikus
Phenotyping of cytochrome P450 3A enzyme in Gujarat population.
January 2008, Drug metabolism letters,
V C Ziesenitz, and J Weiss, and W E Haefeli, and G Mikus
Lack of effect of subject posture on intravenous midazolam clearance: implications for hepatic cytochrome P450 3A phenotyping.
March 2009, British journal of clinical pharmacology,
V C Ziesenitz, and J Weiss, and W E Haefeli, and G Mikus
Comparison of midazolam and simvastatin as cytochrome P450 3A probes.
April 2006, Clinical pharmacology and therapeutics,
V C Ziesenitz, and J Weiss, and W E Haefeli, and G Mikus
Cytochrome P450 3A: genetic polymorphisms and inter-ethnic differences.
October 2005, Methods and findings in experimental and clinical pharmacology,
V C Ziesenitz, and J Weiss, and W E Haefeli, and G Mikus
Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update.
July 2007, Pharmacogenomics,
V C Ziesenitz, and J Weiss, and W E Haefeli, and G Mikus
Endogenous cortisol 6 beta-hydroxylation clearance is not an accurate probe for overall cytochrome P450 3A phenotyping in humans.
October 2009, Clinica chimica acta; international journal of clinical chemistry,
V C Ziesenitz, and J Weiss, and W E Haefeli, and G Mikus
Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.
April 1994, Biochemical pharmacology,
Copied contents to your clipboard!